Can lisdexamfetamine (Vyvanse) cause a false‑positive methamphetamine result on a urine drug screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lisdexamfetamine Will Cause a Positive Amphetamine Screen, Not a False-Positive Methamphetamine Result

Lisdexamfetamine (Vyvanse) is metabolized to dextroamphetamine and will legitimately test positive for amphetamines on urine drug screens—this is an expected true positive, not a false positive. However, it should NOT cause a positive methamphetamine result on properly performed confirmatory testing.

Understanding the Key Distinction

What Actually Happens with Lisdexamfetamine

  • Lisdexamfetamine is a prodrug that is enzymatically converted to dextroamphetamine (d-amphetamine) in the body
  • Patients taking Vyvanse will test positive for amphetamines on both screening immunoassays and confirmatory testing 1
  • This is a "clinical false-positive" in the sense that it detects legitimate prescribed medication use, not illicit drug abuse—but it's not a laboratory false-positive 1

The Methamphetamine Question

Lisdexamfetamine should NOT produce a positive methamphetamine result on proper confirmatory testing. Here's why this matters:

  • Immunoassay screening tests are prone to cross-reactivity and can produce false-positive methamphetamine results from various medications 2, 3, 4, 5
  • Confirmatory testing (GC-MS or LC-MS/MS) is highly specific and should differentiate amphetamine from methamphetamine 1
  • If methamphetamine appears on confirmatory testing in a patient taking only amphetamine products, consider:
    • Pharmaceutical impurity: Trace methamphetamine can exist as an impurity in amphetamine formulations 6
    • A methamphetamine-to-amphetamine ratio <1.125% suggests impurity rather than illicit use 6
    • Ratios >1.125% warrant investigation for possible illicit methamphetamine use

Clinical Algorithm for Interpretation

Step 1: Initial Positive Screen

When a patient on Vyvanse has a positive amphetamine/methamphetamine screen:

  • Expected finding: Positive for amphetamines
  • Requires action: Any methamphetamine positivity

Step 2: Obtain Complete Medication History

  • Document all prescribed medications, including:
    • Lisdexamfetamine (Vyvanse)
    • Other ADHD medications (amphetamine/dextroamphetamine products)
    • Any other medications that could cross-react 1

Step 3: Order Confirmatory Testing

  • Always confirm positive immunoassay results with GC-MS or LC-MS/MS 1
  • Confirmatory testing will distinguish:
    • Amphetamine (expected from Vyvanse)
    • Methamphetamine (NOT expected from Vyvanse)

Step 4: Interpret Confirmatory Results

If only amphetamine is detected:

  • Consistent with prescribed Vyvanse use
  • No further action needed regarding substance abuse

If methamphetamine is detected:

  • Calculate the methamphetamine-to-amphetamine ratio 6
  • Ratio <1.125%: Likely pharmaceutical impurity—document and monitor
  • Ratio >1.125%: Investigate for possible illicit methamphetamine use
  • Consider timing of last dose and detection windows (median 67-69 hours for amphetamine from lisdexamfetamine) 7

Critical Pitfalls to Avoid

Do Not Rely on Immunoassay Alone

  • Immunoassays have significant cross-reactivity issues 2, 3, 4, 5
  • Never make clinical decisions about substance abuse based solely on screening immunoassays 1

Do Not Assume All Positive Results Mean Illicit Use

  • Patients taking prescribed amphetamine medications will test positive for amphetamines—this is appropriate medication use, not abuse 1
  • The guideline explicitly states: "drug testing cannot distinguish between appropriate use and misuse of prescribed medications" 1

Do Not Ignore Low-Level Methamphetamine Findings

  • Small amounts of methamphetamine may represent pharmaceutical impurity 6
  • Consider raising the methamphetamine cutoff to 50-100 ng/mL to reduce false accusations 6

Do Not Forget pH Effects

  • Urinary pH significantly affects amphetamine excretion and detection 8, 7
  • Acidifying agents (vitamin C) decrease amphetamine levels
  • Alkalinizing agents (antacids) increase amphetamine levels
  • Large interindividual variability exists in detection times 7

Documentation Requirements

When interpreting results, document:

  • Complete prescribed medication list
  • Timing of last Vyvanse dose
  • Whether confirmatory testing was performed
  • Methamphetamine-to-amphetamine ratio if both detected
  • Clinical correlation with patient history

The bottom line: Vyvanse causes legitimate amphetamine positivity but should not cause methamphetamine positivity on proper confirmatory testing. Any methamphetamine detection requires confirmatory testing and ratio calculation before concluding illicit use.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.